Melinta Therapeutics (United States)
Melinta Therapeutics is an American biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Melinta Therapeutics (United States), United States, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
65%
Total
Publications
163
Total Open
Publications
106
Total
Citations
4.8K
Open Access
Percentage
65%
Total
Publications
163
Total Open
Publications
106
Total
Citations
4.8K
Breakdown
Publisher Open
27%
Both
32%
Other Platform Open
6%
Closed
35%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 54%
51
Hybrid 25%
24
No Guarantees 21%
20
Other Platform Open
Domain 85%
53
Other Internet 13%
8
Institution 11%
7
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 53 |
DOI | Other Internet | 7 |
Universitat Pompeu Fabra - Repositori digital de la UPF | Institution | 2 |
Europe PMC | Domain | 2 |
Unknown Repository | Other Internet | 1 |
University of Udine - Institutional Research Information System | Institution | 1 |
University of Massachusetts Amherst - Scholarworks | Institution | 1 |
University of Genoa - CINECA IRIS Institutial Research Information System | Institution | 1 |
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB | Institution | 1 |
Repositorio Institucional | Institution | 1 |